Dr. Lin Ting-an, a hematologist, consistently dedicates herself to research outside of her clinical duties. In collaboration with this research team, she has achieved academic results with significant clinical value. Her paper “Cryptococcal antigen cross-reactivity is associated with fatal trichosporonosis in patients with hematologic diseases” has been officially published in European Journal of Clinical Microbiology & Infectious Diseases, appearing in the December 2025 issue, Vol. 44, No. 12, pp. 2955–2964.
This study focuses on invasive trichosporonosis in patients with hematologic diseases. A retrospective analysis was conducted on inpatient data from a single medical center between 2004 and 2023. Among 6,169 hospitalized patients with hematologic diseases, 88 cases with positive Trichosporon cultures were identified. The study further investigated their risk factors, clinical characteristics, and prognosis. The results indicate that long-term corticosteroid therapy and broad-spectrum antibiotic use are associated with an increased risk of invasive infection. Such infections often present as breakthrough infections and frequently occur during echinocandin therapy.
The study also points out that second-generation triazole antifungals, particularly voriconazole, are associated with better treatment outcomes. Furthermore, cryptococcal antigen cross-reactivity is significantly associated with fatal trichosporonosis. This not only highlights the need for careful interpretation in clinical diagnosis but also suggests its potential as an important clue for early identification and prognostic assessment. This finding offers important clinical insights for the early diagnosis and appropriate treatment strategies for invasive fungal infections in patients with hematologic diseases.
Completing this research, which combines academic depth with practical significance, and achieving publication in an international journal, while managing a demanding clinical workload, is truly commendable. This not only demonstrates Dr. Lin Ting-an's excellent capabilities in clinical research, data analysis, and academic writing but also reflects her continuous attention and dedication to infectious disease issues in hematologic patients. We extend our sincere congratulations and hope that Dr. Lin will continue to excel in her clinical profession and academic research, publishing more impactful achievements in the future.
Reference: https://pubmed.ncbi.nlm.nih.gov/40971015/